Bangalore Medical Service Trust partners with Germany-based DKMS to help blood cancer patients

S Singh
S Singh
· 3 min read

Bangalore Medical Service Trust (BMST), a centre of excellence in the areas of blood banking, transfusion and immunohematology in Bengaluru has partnered with DKMS a non-profit organisation dedicated to fight against blood cancer and other blood disorders. The partnership will provide a large pool of potential blood stem cell donors for patients suffering from blood cancer and other blood disorders.

Dr Biju George, Head, Department of Haematology, CMC Vellore said, “Every five minutes someone in India is diagnosed with blood cancer and other blood disorders wherein leukaemia, lymphoma and myeloma are the top three forms to be found. While blood cancer is life-threatening, a set of healthy blood stem cells from a matching donor can be life-saving”.

The registry DKMS-BMST at present has over 27,000 registered potential blood stem cell donors. This number will increase considerably over the years with the aim of finding a matching donor for every patient in need.

Highlighting the impact of the myths that exist in India, Dr Latha Jagannathan, Medical Director, Managing Trustee, BMST said, “Many patients suffering from blood cancer and other blood disorders need a blood stem cell transplant to survive. Unfortunately the majority of patients are never able to receive a transplant due to the unavailability of a matching blood stem cell donor. In India, only 0.03 per cent of the total population is registered as a potential blood stem cell donor. This is significantly lower than many other countries including the US where 2.7 per cent and Germany where 10 per cent of the population is registered as a potential donor. A lack of understanding and multiple baseless misconceptions existing amongst people about the process, impacts the cause. It is high time that we all overcome this and commit to being a life saver to save our children”.

“Every year, about 80,000 donor searches are initiated across the globe. Mainly due to the lack of a matching donor, India has one of the highest ratios of searches that do not result in transplantation. At DKMS, we are working to find a donor for every patient in need and require your support in achieving the same here in India. Through this venture with BMST, we are delighted to be able to save many more lives, but we still need to do more. Indian patients mainly require an Indian tissue match which means that we need to increase the awareness and encourage many more people in India to register as a blood stem cell donor. It only takes a few minutes to register as a potential donor. All that is required is a simple swab of the inside of your cheeks to determine your HLA characteristics – so please come forward and join the registry”, said Dr Elke Neujahr, Global Chief Operating Officer, DKMS.

 

 

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk